ARTICLE | Company News
Icos licenses Afferon's RTX
November 5, 2001 8:00 AM UTC
ICOS exclusively licensed from Afferon (Wayne, Penn.) worldwide rights to RTX resiniferatoxin to treat urological disorders. ICOS will pay an upfront license fee, milestones and royalties. In addition, ICOS develop and commercialize RTX and its analogs. ...